Stocks to sell

S&P 500 companies have reported strong earnings this season, with 79% surpassing profit expectations, according to Bloomberg’s data. However, these results have not significantly bolstered stock performance, with the median stock outperforming the index by less than 0.1% on the day earnings were announced, despite some sectors facing analyst downgrades. This marginal gain marks the
0 Comments
The stock market has been on an incredible run over the past year with tech and growth stocks surging. Traders have piled into many fast-moving companies in hopes of locking in quick trading gains. This excitement has increasingly moved back into the meme stock arena as well. While meme stocks somewhat fell out of fashion in 2022 and 2023, they are firmly back
0 Comments
From its stellar performance in 2021 to deflating in 2022, the biotech sector continued its stagnation into 2023, highlighting some pharma stocks to avoid. Year-to-date, the S&P Biotechnology Select Industry Index has dropped by 4%. Likewise, the number of biotech firms shrunk by 3% in 2023. Although overlapping with the biotech sector, pharma stocks have
0 Comments
Consumer interest has definitely has started to shift away from EV stocks with many investors choosing to sell them in favor of conventional combustion engine companies. Everything from government subsidies to concerns about climate change has spurred growth in the sector. However, since the beginning of the U.S. Federal Reserve’s 2022 rate hike cycle, the
0 Comments
Investors should always pay close attention to stocks with lowered price targets. Not only can that lowered target highlight potential danger, but it can also highlight a potential short opportunity to be well aware of. Often, downgraded and downward price revisions are influenced by company fundamentals, including financial health and future growth. They can also
0 Comments